|
The impact of COVID-19 pandemic on access to new patient cancer care as evaluated in the Integra Connect Database (ICD). |
|
|
Employment - IntegraConnect |
Stock and Other Ownership Interests - Becton Dickinson; Boston Scientific (I); Cerner (I); Gilead Sciences (I) |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Employment - Florida Cancer Specialists |
|
|
|
Employment - IntegraConnect |
|
|
Employment - IntegraConnect |
|
|
Employment - IntegraConnect |
|
|
Employment - IntegraConnect |
Honoraria - Caris Life Sciences; Janssen Oncology |
Consulting or Advisory Role - Pfizer |
|
|
Employment - IntegraConnect |
|
|
Employment - IntegraConnect |
Consulting or Advisory Role - Celgene; Celgene |
Travel, Accommodations, Expenses - Celgene |